abstract |
According to a composition, kit, and method for diagnosing resistance to a taxane anticancer agent, a composition for treating taxane anticancer agent-resistant cancers, and a method for screening substances for same, taxane anticancer agent-resistant cancers can be efficiently diagnosed or treated, and candidate substances that can treat taxane anticancer agent-resistant cancers can be efficiently screened. |